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S
ubarachnoid hemorrhage (SAH) is a stroke subtype associated with high mortality and morbidity as a result of early and delayed ischemic processes. Nearly one quarter of all patients with SAH die shortly after hemorrhage because of elevated intracranial pressure (ICP) and the resulting global cerebral ischemia. 1, 2 Hospitalized patients further experience severe complications, including rebleeding, early brain injury, and delayed cerebral ischemia, which together contribute to a devastatingly high 1-month mortality rate of 50%. 1, 2 Early brain injury is the predominant cause of death after SAH and is characterized by elevated ICP, decreased cerebral blood flow (CBF), and global cerebral ischemia resulting in secondary injuries, including disruption of the blood-brain barrier, inflammation, and oxidative stress, which all cause neuronal cell death. [3] [4] [5] In both animal and clinical studies, the severity of bleeding and the extent of decreased CBF correlated with neurological outcome [6] [7] [8] ; however, how and to what extent the initial global ischemia or subsequent elevated ICP contribute to early brain injury remains poorly understood. [3] [4] [5] A feasible way to reduce elevated ICP is decompressive craniectomy (DC), a technique that dates back more than a century. 9 In recent years, both animal and clinical studies reported beneficial effects of DC for treating conditions, such as traumatic brain injury 10, 11 and malignant middle cerebral artery (MCA) infarction. 12, 13 With respect to SAH, however, relatively few studies have been published regarding the application of DC and its effect on outcome; moreover, the results published to date are contradictory and controversial. [14] [15] [16] [17] [18] To address these questions, we performed DC to evaluate the role of SAH-induced elevated ICP and subsequent global ischemia and to investigate whether DC may serve as a therapeutic option for SAH using a standardized animal model.
Methods
In total, 41 male C57BL/6 mice (22-25 g; Charles River Laboratories, Sulzfeld, Germany) were used. All experiments were approved by the Government of Upper Bavaria (protocol number 55.2.1.54-2532-90-13) and were performed in accordance with standard ethical guidelines.
Experimental Design
Initially, 40 animals were assigned randomly to the following 4 experimental groups: sham surgery, SAH, DC after SAH, and DC before SAH (Figure 1 ). All assessments were performed by an 2
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investigator blinded with respect to the treatment group. Because the first 5 mice in the DC before SAH group experienced high morbidity and failed to reach the 7-day end point, for ethical reasons we stopped this group after 5 mice. In addition, a DC plus sham surgery group with 6 animals was performed to evaluate potential effects caused by craniectomy under normal conditions.
Anesthesia and Monitoring
Mice were anesthetized and monitored as previously described.
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Anesthesia was induced using 4% isoflurane inhalation followed by an intraperitoneal injection of fentanyl (0.05 mg/kg), midazolam (5 mg/kg), and medetomidine (0.5 mg/kg); anesthesia was maintained by hourly injections containing one-third of the initial dose of anesthetics. After induction, mice were intubated and mechanically ventilated (Minivent, Hugo Sachs, March-Hugstetten, Germany) with a 70%/30% air/oxygen gas mixture, and end-tidal PCO 2 was measured using microcapnometry (CI240, Columbus Instruments, Columbus, OH). A thermostatically regulated feedback-controlled heating pad (FHC, Bowdoin, ME) was used to maintain a rectal temperature of 37°C. Preemptive postoperative analgesia was provided with carprofen (4 mg/kg SC). For continuous monitoring of ICP, a cranial burr hole was drilled under continuous cooling with saline, and an ICP transducer (Codman, Johnson & Johnson, Berkshire, UK) was introduced in the epidural space over the right hemisphere (Figure 1 ). Regional CBF was measured continuously using a flexible laser Doppler flowmetry probe (PeriFlux System 5000, Perimed, Järfälla, Sweden) glued onto the left temporal bone above the territory of the left MCA (Figure 1 ). The ICP and laser Doppler flowmetry probes were removed at the end of the monitoring period.
Decompressive Craniectomy
DC was performed either before or 15 minutes after SAH induction ( Figure 1 ). To achieve a sufficient reduction in ICP, the skull bone was removed over both hemispheres (left, 8×4 mm; right, 4×4 mm; Figure 1 ) using a high-speed drill (Labset Uni-Drive N, Paggen, Starnberg, Germany) under continuous cooling with saline. Special attention was paid to leave the dura mater intact.
Endovascular Perforation Model for SAH Induction
The endovascular perforation model for inducing SAH was performed as previously described. [19] [20] [21] In brief, the neck was opened by a midline incision, and the left common carotid artery was exposed. A 5-0 monofilament was introduced into the internal carotid artery via the external carotid artery and advanced toward the Circle of Willis. To induce SAH, the vessel wall was perforated close to the bifurcation between the anterior cerebral artery and the MCA; successful induction was confirmed by a sudden steep increase in ICP and a concomitant decrease in CBF. Then, the filament was withdrawn and the external carotid artery was ligated. In sham-operated animals, the monofilament was introduced into the internal carotid artery, but without vessel perforation. Rebleeding events resulted in an additional sudden increase in ICP above 25 mm Hg.
Postoperative Care
At the end of surgery, the probes were removed and both the neck incision and the skin above the craniectomy were carefully closed. Anesthesia was terminated by a subcutaneous injection containing atipamezol (2.5 mg/kg), flumazenil (0.5 mg/kg), and naloxone (1.2 mg/kg). To prevent hypothermia, the animals were housed in an incubator with an ambient temperature of 30°C for 24 hours after surgery. For a period of 7 days, the mice were observed and received daily subcutaneous injections of carprofen (4 mg/kg) and 0.2 mL saline.
Neurological Evaluation and Body Weight
Daily neurological examinations were performed beginning 2 days before surgery until 7 days after surgery using a global SAH neuroscore (see Table I in the online-only Data Supplement; adapted from Bühler et al). 21 Mice received a score ranging from 0 (no deficit) to 31 (severe neurological deficits). The tests were performed at approximately the same time each day (evening) to avoid any potential effect of circadian rhythm.
In addition, body weight was measured daily as a sensitive indicator of general well-being.
Tissue Harvesting and Histology
Seven days after surgery, the animals were euthanized under anesthesia by transcardial perfusion with 4% paraformaldehyde. The brains were harvested and postfixed in 4% paraformaldehyde for 24 hours. Coronal sections (4 μm) were stained with cresyl violet for subsequent histological analysis.
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Evaluation of Hydrocephalus and White Matter Damage
To measure hydrocephalus, 2 sections (100 μm apart, at Bregma +1 mm) were imaged, and the area of both ventricles, as well as total brain area, was measured using AxioVision software (Zeiss, Jena, Germany). Results are expressed as ventricle area divided by total brain area (ie, relative ventricle area).
To assess white matter damage, the most dorsal point (turning point) of the corpus callosum on both hemispheres (at Bregma +1 mm) was identified, and the perpendicular extent of the corpus callosum was measured. Results are expressed as the mean of 2 sections.
Quantification of Neuronal Damage
To quantify neuronal damage, sections between Bregma −1.6 mm and −2 mm were imaged. Regions of interest (0.3×0.2 mm 2 ) were http://stroke.ahajournals.org/ Downloaded from selected in the CA1, CA2, and CA3 regions of the hippocampus, and viable pyramidal neurons were counted as previously described. [19] [20] [21] Neurons were counted in 3 sections (at 50-μm intervals), and the results are expressed as the mean of these 3 sections.
Statistical Analysis
Statistical analysis was performed using SigmaPlot 12.5 (Systat Software Inc., San Jose, CA) and Excel 2010 (Microsoft Corporation, Redmond, WA). The data were analyzed using either the MannWhitney test (for pairwise comparisons) or the Kruskal-Wallis 1-way analysis of variance on ranks followed by Dunn's method as a post hoc test. Paired data were analyzed using the Wilcoxon signed-rank test. Mortality was analyzed using the LogRank test. Differences were considered statistically significant at P<0.05. Except where indicated otherwise, all data are expressed as mean±SEM.
Results
Physiological Monitoring
SAH induction caused an immediate increase in ICP (from a baseline of 5 mm Hg to >50 mm Hg; P<0.001 versus sham; Figure 2A Figure 2A and 2B).
SAH induction also caused a dramatic concomitant decrease in ipsilateral CBF to <20% of baseline (P<0.001 versus sham; Figure 2C ). All 3 SAH groups had a similar initial drop in CBF; however, 15 minutes after SAH, the DC Figure 2C and 2D). DC performed in mice with sham surgery had no significant influence on these physiological parameters or on the following functional and histological outcome (see Figure I and II in the online-only Data Supplement).
All animals in the study had similar physiological parameters throughout anesthesia (see Figure III in the online-only Data Supplement). The observed decrease in heart rate after SAH induction is part of the Cushing response to elevated ICP.
Rebleeding
The mice in the DC before SAH group had a higher incidence of rebleeding (80%) compared with the SAH group (50%) and the DC after SAH group (40%; Figure 3A ). In addition, these mice also showed a higher rate of rebleedings per animal (0.5±0.2 for SAH, 0.4±0.2 for DC after SAH, and 1.4±0.5 for DC before SAH; Figure 3B ).
Neuroscore and Body Weight
Evaluation of daily neuroscore values revealed the most severe deficits on the first day after SAH induction; moreover, mice that underwent DC performed significantly poorer (ie, higher neuroscore values) than the mice in the SAH group (4±1 for sham, 8±2 for SAH, 12±2 for DC after SAH, 18±7 for DC before SAH; P<0.05; Figure 4A ). This difference in scores remained significant 5 days after surgery. Table I in the online-only Data Supplement) on the first day after surgery, and all groups recovered gradually. The mice with decompressive craniectomy (DC) had significantly worse neuroscores in the first 5 days compared with the SAH group. B, All groups had a considerable decrease in body weight in the first 3 days after surgery. The mice in the DC before SAH group and the DC after SAH group had significantly more weight loss and recovered more slowly than the Sham and SAH group. C, All mice with DC before SAH died within the first 7 days after hemorrhage. A loss in body weight could be seen in all 4 study groups; however, the mice in the 2 groups that underwent DC had the largest decrease ( Figure 4B ). In addition, these 2 groups recovered their body weight significantly more slowly than the sham and SAH groups.
Mortality
We also observed a significant difference in mortality rate between study groups, showing higher mortality for mice with DC (P<0.001; Figure 4C ). In the DC before SAH group, no mouse survived until day 7, and some animals developed massive ventricular protrusions that resulted in the rupture of the dura mater and prolapsed brain parenchyma through the craniectomy (see Figure IV in the online-only Data Supplement). Therefore, because of ethical considerations and regulatory issues, only 5 animals were used in this group. In addition, because all 5 mice in this group died before the 7-day end point, no histomorphometry or histopathology data were available for this group.
Histomorphometry
Seven days after surgery, ventricle size was determined in coronal sections as a measure of hydrocephalus (1.2%±0.1% for sham, 2.5%±0.3% for SAH; P<0.001; Figure 5A ). Performing DC after SAH had no significant effect on relative ventricle area (2.5%±0.3% for SAH, 2.3%±0.3% for DC after SAH).
The corpus callosum was significantly thinner in the ipsilateral hemisphere compared with the contralateral hemisphere in both the SAH and DC after SAH groups ( Figure 5B ). This difference between the ipsilateral and contralateral hemispheres in the SAH groups was also reflected by a significant decrease in the ipsilateral/contralateral thickness ratio (1.00±0.01 for sham, 0.88±0.01 for SAH, and 0.91±0.04 for DC after SAH; P<0.01; Figure 5C ). There was no difference between the SAH group and the DC after SAH group.
Histopathology
There was a significant loss of viable pyramidal neurons in all regions of interest 7 days after SAH ( Figure 6 ). DC had no significant effect on neuronal survival, but there was a tendency toward increased neuronal loss in all 4 regions studied in the ipsilateral hippocampus.
Discussion
Performing DC-either before or after SAH inductionreduced ICP significantly; however, the mice in the DC groups experienced a higher incidence of rebleeding, poorer functional outcome, and increased mortality. In comparing Figure 5 . Histomorphometric evaluation 7 days after surgery. A, Relative ventricle area (ventricle area divided by total brain area) was measured in cresyl violet-stained coronal sections. Both the subarachnoid hemorrhage (SAH) and the decompressive craniectomy (DC) after SAH groups had significantly enlarged ventricles (arrows), a sign of hydrocephalus. DC had no effect on the extent of SAH-induced hydrocephalus. Evaluation of SAH-induced white matter damage-measured by corpus callosum thickness (B) and ipsilateral/contralateral ratio (C)-showed a lateralized effect ipsilateral to SAH induction.
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the SAH group with the DC after SAH group, we were surprised to find that the CBF values were not affected by DC, despite the DC-induced reduction in ICP. This finding suggests that within minutes after SAH, cerebral hypoperfusion is not dependent on ICP, but is dependent on spasms in cerebral microcirculation, which supports recent findings by our group and others. 22, 23 The experiments in this study were performed in intubated and ventilated mice, with all relevant physiological parameters monitored. This experimental set-up enabled us to detect, control, and therefore exclude any potential systemic artifacts in our animals. A second advantage of our experimental approach is our use of an SAH model in which hemorrhage is induced by vascular perforation; only this method revealed that DC caused rebleeding that led to a high mortality rate and poor functional outcome. Using a different SAH model (eg, injecting a predetermined volume of blood) would not have revealed these results because in these models rebleeding does not occur.
One goal of our study-specifically, to clarify the role of early ICP-induced global cerebral ischemia in brain damage after SAH-could not be achieved. The primary reason why we did not reach this goal was that both end points required for determining such a correlation were not reached. First, the mice maximally decompressed before SAH developed posthemorrhagic intracranial hypertension that was on par with mice that were not decompressed-indicating more severe hemorrhage leading to a larger hematoma in decompressed mice; second, none of these animals survived to the end of the 7-day observation period. Nevertheless, rather than answering our initial question, these experiments revealed 2 other important points. First, in addition to its detrimental effect (in terms of rapidly inducing global ischemia), the initial peak in ICP after SAH has also a beneficial aspect because it helps stop bleeding from the injured vessel and helps prevent rebleeding.
These findings support the concept of a brain tamponade 24 in which high ICP stops post-SAH bleeding, and these results are consistent with previous findings from our laboratory, which show that preventing rebleeding is highly beneficial after experimental SAH. 25 The second important point revealed by our results is that reduced ICP does not improve CBF. This ICP-independent reduction in CBF might reflect the early onset of microvasospasm 22, 23 and may account for the similar or worse pathophysiological findings in our study-in accordance with early brain injury.
Because our animal model recapitulates the predominant secondary pathologies after SAH, we were able to investigate further effects of DC on functional outcome. Performing established neurological examinations 21 revealed that DC is associated with aggravated functional outcome, which is also reflected by the more affected body weight changes. In addition to hydrocephalus formation (as a result of reduced reabsorption of cerebrospinal fluid), 3 several studies have reported hippocampal damage as a sensitive marker for neuronal damage in this model. 19, 26 In our study, the mice in the DC after SAH group did not have significantly worse damage than the SAH group, but they showed a tendency toward more neuronal cell death in the ipsilateral hippocampus.
White matter injury associated with SAH is a relatively poorly investigated field that has only recently begun to be addressed in more detail. 27, 28 In our study, we found histological changes 7 days after SAH, and comparison of corpus callosum thickness of both hemispheres indicated white matter thinning ipsilateral to the SAH induction site. Similar observations were reported recently in a rat model. 27 One possible explanation for this lateralization effect may be the presence of a more pronounced vasospasm near the initial bleeding site. 29 Many studies have investigated the role of DC in traumatic brain injury 10, 11 and malignant MCA infarction, 12,13 and the beneficial effects of DC in malignant MCA infarction have led to the recommendation of including DC in current treatment guidelines. 30 However, only a few case reports describe the application of DC in SAH patients, [14] [15] [16] [17] [18] and the results of these reports are controversial because of different time points and indications for DC. For example, in patients with intractable intracranial hypertension or signs of brain swelling, DC can have a beneficial effect on functional outcome, [16] [17] [18] whereas DC has no benefit in cases of delayed cerebral ischemia. 18 However, when looking in further detail at long-term quality of life rather than survival rate, the positive effects seem to be diminished by a reduced overall quality of life in craniectomized patients, 14 which is consistent with our results, despite the early, clinically not relevant time points of DC in the current study. Therefore, randomized controlled clinical trials are urgently needed to clarify the indication and consequences of DC in SAH patients.
In summary, although performing DC either before or after SAH effectively reduced ICP, it did not induce an overall beneficial effect. In contrast, decompression before SAH resulted in a higher incidence of rebleeding and a higher mortality rate. Therefore, because posthemorrhagic ICP elevation seems to play an important role in the cessation of bleeding, it should not be reduced directly after SAH. Mechanistically, our data suggest that the hypoperfusion observed directly after SAH is not caused by elevated ICP, but is likely caused by microcirculatory dysfunction. This hypothesis is based on the finding that DC did not affect posthemorrhagic hypoperfusion, despite reducing ICP. Taken together, our results reveal that DC does not have a net beneficial effect when performed early after SAH. Therefore, clinical evaluations should pay particular attention to both the degree of bleeding and the timing of decompression. 
